Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1993
03/04/1993WO1993004174A1 Ryegrass pollen allergen
03/04/1993WO1993004173A1 Immunoglobulin variants for specific fc epsilon receptors
03/04/1993WO1993004172A2 Gene encoding a human beta-casein process for obtaining the protein and use thereof in an infant formula
03/04/1993WO1993004171A1 Human beta-casein, process for producing it and use thereof
03/04/1993WO1993004170A1 Raf protein kinase therapeutics
03/04/1993WO1993004168A1 Transgenic non-human animal model for developing and testing therapies to treat sepsis
03/04/1993WO1993004166A1 Purine-region dna binding protein
03/04/1993WO1993004163A1 Strain of chlamydia
03/04/1993WO1993004089A1 Hepatitis c assay utilizing recombinant antigens from ns5 region
03/04/1993WO1993004088A1 Hepatitis c assay utilizing recombinant antigens to ns1
03/04/1993WO1993004087A1 Hepatitis c assay utilizing recombinant antigens to c-100 region
03/04/1993WO1993004086A1 Receptors for advanced glycosylation endproducts and uses thereof
03/04/1993WO1993004085A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof
03/04/1993WO1993004084A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same
03/04/1993WO1993004083A1 Human calcium channel compositions and methods
03/04/1993WO1993004082A1 Analogs of hirudin
03/04/1993WO1993004081A1 Peptides having growth hormone releasing activity
03/04/1993WO1993004079A1 Method for generating and screening useful peptides
03/04/1993WO1993004078A1 Gene encoding mutant l3t4 protein which facilitates hiv infection and transgenic mouse expressing such protein
03/04/1993WO1993003769A1 Adenovirus mediated transfer of genes to the gastrointestinal tract
03/04/1993WO1993003766A1 Multiple antigen peptides for use as hiv vaccines
03/04/1993WO1993003764A1 Hla-restricted hepatitis b virus ctl epitopes
03/04/1993WO1993003763A1 Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
03/04/1993WO1993003762A1 Immunostimulation
03/04/1993WO1993003761A1 METHODS AND COMPOSITIONS RELATING TO USEFUL ANTIGENS OF $i(MORAXELLA CATARRHALIS)
03/04/1993WO1993003759A1 Papua new guinea human t-lymphotropic virus
03/04/1993WO1993003758A1 Production of homogeneous neurotrophic factor
03/04/1993WO1993003757A1 Muteins of epidermal growth factor exhibiting enhanced binding at low ph
03/04/1993WO1993003755A2 Use of relaxin in cardiovascular therapy and in the treatment of neurodegenerative diseases
03/04/1993WO1993003753A1 Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus
03/04/1993WO1993003750A1 PROTEINS USEFUL IN THE REGULATION OF λB-CONTAINING GENES, CORRESPONDING DNA AND RNA SEQUENCES
03/04/1993WO1993003749A1 Methods and compositions for modulating g protein action
03/04/1993WO1993003748A1 Modulation of blood pressure and inhibition of platelet activation with kininogen fragment
03/04/1993WO1993003747A1 STABILIZED IL-1α PHARMACEUTICAL PREPARATION
03/04/1993WO1993003709A1 Composition and method for treating cystic fibrosis
03/04/1993WO1993003707A1 Phosphopeptides for the treatment of dental calculus
03/04/1993WO1993003619A1 Multi-targeted bacillus thuringiensis bioinsecticide
03/04/1993WO1992020796A3 D-type cyclin and uses related thereto
03/04/1993WO1992018160A3 Method for inhibiting adhesion of white blood cells to endothelial cells
03/04/1993CA2116359A1 Anti-hiv proteins gap 31, dap 30, and dap 32, dna coding therefor and therapeutic uses thereof
03/04/1993CA2116013A1 Method for generating and screening useful peptides
03/04/1993CA2116012A1 Transgenic non-human animal model for developing and testing therapies to treat sepsis
03/04/1993CA2115926A1 Hepatitis c assay utilizing recombinant antigens to ns1
03/04/1993CA2115925A1 Hepatitis c assay utilizing recombinant antigens from ns5 region
03/04/1993CA2115923A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same
03/04/1993CA2115833A1 Purine-region dna binding protein
03/04/1993CA2115742A1 Adenovirus mediated transfer of genes to the gastrointestinal tract
03/04/1993CA2115674A1 Dna sequencing with a t7-type gene 6 exonuclease
03/04/1993CA2115554A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines
03/04/1993CA2115550A1 Gene encoding a human beta-casein, process for obtaining the protein and use thereof in an infant formula
03/04/1993CA2115424A1 Immunostimulation
03/04/1993CA2115364A1 Composition and method for treating cystic fibrosis
03/04/1993CA2114434A1 Screening methods for immunosuppressive agents
03/04/1993CA2114016A1 Methods and compositions for modulating g protein action
03/04/1993CA2113925A1 Yeast promoter and use thereof
03/03/1993EP0529995A1 Human KA-2 receptor, a kainate high affinity receptor of the EAA2 (Excitatory Amino Acid) family
03/03/1993EP0529994A1 Human KA-1 receptor, a kainate high affinity receptor of the EAA1 (Excitatory Amino Acid) family
03/03/1993EP0529742A1 Alpha-amidating enzyme compositions and processes for their production and use
03/03/1993EP0529719A1 Assay for evaluating inhibition of PMN elastase by N-Substituted Azetidinones
03/03/1993EP0529622A2 Cloning and characterization of a cardiac adenylyl cyclase
03/03/1993EP0529584A2 Viral agent associated with the Mystery Swine Disease
03/03/1993EP0529568A1 Novel orally-active elastase inhibitors
03/03/1993EP0529504A2 Apparatus for the simultaneous synthesy of different peptides
03/03/1993EP0529493A2 Methods and reagents for hepatitis C detection
03/03/1993EP0529487A2 PACAP derivatives having c-AMP producing activity
03/03/1993EP0529469A2 Substituted 2,3-diamino acids, process for their preparation and their use as intermediates for peptidic agents
03/03/1993EP0529300A1 Novel recombinant human-IFN-beta, process for the preparation thereof and pharmaceutical compositions comprising the same
03/03/1993EP0529175A1 Conjugates chelated with paramagnetic metals for targetting
03/03/1993EP0529160A1 Gene protein products and methods of cell therapy
03/03/1993EP0529086A1 Processes for purifying human bcdf
03/03/1993EP0529075A1 Hybrid calcitonin
03/03/1993EP0529065A1 Receptor-based screening methods for amylin agonists and antagonists
03/03/1993EP0529033A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
03/03/1993EP0529031A1 Improved inhibitors of thrombin
03/03/1993EP0529030A1 Composition of antibodies directed against the humain or animal interleukin-2 receiver
03/03/1993EP0529023A1 Therapeutically useful peptides and peptides fragments
03/03/1993EP0529010A1 Mammalian cells expressing a hybrid receptor.
03/03/1993EP0529008A1 Modulation of gene expression through interference with rna secondary structure
03/03/1993EP0529007A1 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION
03/03/1993EP0528979A1 $i(TRANS)-DOMINANT SUPPRESSOR GENES FOR OLIGOMERIC PROTEINS
03/03/1993EP0528949A1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample.
03/03/1993EP0528926A1 Soluble peptide analogues containing binding sites
03/03/1993EP0528878A1 A hybrid cellular receptor
03/03/1993EP0528870A1 Protein-nucleic acid probes and immunoassays using same
03/03/1993EP0528861A1 Composition and treatment with biologically active peptides and toxic cations
03/03/1993EP0528857A1 New bacillus thuringiensis strains and their genes encoding insecticidal toxins
03/03/1993EP0528841A1 A method for the preparation of pyridoxylated hemoglobin
03/03/1993EP0528835A1 Cyclic peptides and their use
03/03/1993EP0528827A1 Protein partner screening assays and uses thereof.
03/03/1993EP0528823A1 BACILLUS THURIGIENSIS cryIF GENE AND PROTEIN TOXIC TO LEPIDOPTERAN INSECTS
03/03/1993EP0528820A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase.
03/03/1993EP0528819A1 Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells
03/03/1993EP0517805A4 Identification and expression of insect steroid receptor dna sequences
03/03/1993EP0127681B1 Iga binding protein
03/03/1993CN1069522A Intercellular adhesion molecule-3 and its binding ligands
03/02/1993US5191068 Removal of cells from an aqueous suspension
03/02/1993US5191067 For treatment of fibroblast growth factor mediated pathophysiological conditions
03/02/1993US5191064 Immunology
03/02/1993US5191063 Production of biologically active polypeptides by treatment with an exogenous peptide sequence
03/02/1993US5191015 Polymers and polymer-peptide conjugates
1 ... 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 ... 2916